A series of monthly calls for ACT psychiatric care providers. Offered in collaboration with the Institute for Best Practices at the University of North Carolina.
Assertive Community Treatment (ACT) is a multidisciplinary, team-based model that provides intensive community-based and outreach-oriented services to people who experience the most severe and persistent mental illness. The vast majority also have a co-occurring substance use disorder and many experience comorbid medical illnesses.
The Northwest MHTTC is hosting a series for ACT psychiatric care providers. We welcome all ACT psychiatrists, nurse practitioners, and other prescribers. Sessions will be held once a month on Thursdays at 12:00-1:30 pm Pacific/3:00-4:30 pm Eastern, May-July 2024.
Learn more about the series and upcoming sessions here.
Our second session on June 20th discussed Clozapine and long-acting injectables (LAI). Learn more about the series and upcoming sessions here.
Dr. Robert O. Cotes is an Associate Professor at Emory University School of Medicine in the Department of Psychiatry and Behavioral Sciences. He serves as Physician Expert for SMI Adviser (www.smiadviser.org), which is funded by the Substance Abuse and Mental Health Services Administration and administered by the American Psychiatric Association. SMI Adviser provides evidence-based resources to clinicians, individuals with serious mental illness, and their families. He is Director of the Clinical & Research Program for Psychosis at Grady Health System, which comprises of three clinical programs. The PSTAR Clinic provides evidence-based, recovery-oriented care for individuals with persistent symptoms of psychosis, specializing in the use of clozapine. Project ARROW is a coordinated specialty care team for people experiencing early psychosis, offering comprehensive, person-centered care using a multidisciplinary approach. Youth and Family TREE provides care to adolescents and young adults with a mental health condition and substance use. Dr. Cotes is an investigator for multiple research studies focused on treatment options for people with psychosis. His research focuses on clozapine and early psychosis.
